JW Kupiec-Weglinski

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Living Beings

Physiology

Chemicals & Drugs

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Korom S; De Meester I; Maas E; Stein A; Wilker S; Jung F; Weimer R; Brendel M D; Ernst W; Friemann S; Linder R; Grimm H; Padberg W; Scharpé S; Kupiec-Weglinski J W; Schwemmle K
CD26 expression and enzymatic activity in recipients of kidney allografts.
Stadlbauer T H; Schaub M; Magee C C; Kupiec-Weglinski J W; Sayegh M H
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Korom S; De Meester I; Coito A J; Graser E; Pratschke J; König S; Grimm H; Volk H D; Scharpé S; Kupiec-Weglinski J W
CD26/DPP IV-mediated modulation of acute rejection.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of JW Kupiec-Weglinski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2002: Korom S; De Meester I; Maas E; Stein A; Wilker S; Jung F; Weimer R; Brendel M D; Ernst W; Friemann S; Linder R; Grimm H; Padberg W; Scharpé S; Kupiec-Weglinski J W; Schwemmle K
CD26 expression and enzymatic activity in recipients of kidney allografts.
Transplantation proceedings 2002;34(5):1753-4.
2000: Stadlbauer T H; Schaub M; Magee C C; Kupiec-Weglinski J W; Sayegh M H
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(6):566-75.
1999: Korom S; De Meester I; Coito A J; Graser E; Pratschke J; König S; Grimm H; Volk H D; Scharpé S; Kupiec-Weglinski J W
CD26/DPP IV-mediated modulation of acute rejection.
Transplantation proceedings 1999;31(1-2):873.
1999: Korom S; De Meester I; Schmidbauer G; Pratschke J; Brendel M D; Durinx C; Schwemmle K; Haemers A; Scharpé S; Kupiec-Weglinski J W
Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity.
Transplantation proceedings 1999;31(1-2):778.
1998: Onodera K; Volk H D; Ritter T; Kupiec-Weglinski J W
Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):5765-72.
1998: Kato H; Onodera K; Chandraker A; Volk H D; Sayegh M H; Kupiec-Weglinski J W
CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
Transplantation proceedings 1998;30(4):1063-4.
1998: Coito A J; Korom S; Hancock W W; Kupiec-Weglinski J W
Blockade of alpha 4 beta 1-integrin-fibronectin adhesive interactions prevents chronic allograft rejection in sensitized recipients.
Transplantation proceedings 1998;30(4):939-40.
1998: Korom S; Hancock W W; Coito A J; Kupiec-Weglinski J W
Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients. II. Treatment with connecting segment-1 peptides prevents chronic rejection by attenuating arteriosclerotic development and suppressing intragraft T cell and macrophage activation.
Transplantation 1998;65(6):854-9.
1998: Coito A J; Korom S; Graser E; Volk H D; Van De Water L; Kupiec-Weglinski J W
Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression.
Transplantation 1998;65(5):699-706.
1998: Onodera K; Chandraker A; Korom S; Stadlbauer T H; Kato K; Kasai S; Sayegh M H; Kupiec-Weglinski J W
Agonistic and antagonistic interactions between CTLA4Ig and donor alloantigens in sensitized rat recipients of cardiac allografts.
Transplantation proceedings 1998;30(1):16-8.
1998: Onodera K; Chandraker A; Volk H D; Lehmann M; Korom S; Stadlbauer T H; Kato K; Kasai S; Sayegh M H; Kupiec-Weglinski J W
Role of regulatory T cells in the "infectious" tolerance pathway in transplant recipients.
Transplantation proceedings 1998;30(1):13-5.
1997: Stadlbauer T H; Schaub M; Korom S; Onodera K; Sayegh M H; Kupiec-Weglinski J W
CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
Transplantation 1997;64(12):1816-22.
1997: Kupiec-Weglinski J W; Colto A J; Van De Water L
Extracellular matrix proteins and their interactions with the cellular repertoire of transplant recipients.
Transplantation proceedings 1997;29(6):2601-2.
1997: Onodera K; Chandraker A; Schaub M; Stadlbauer T H; Korom S; Peach R; Linsley P S; Sayegh M H; Kupiec-Weglinski J W
CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(4):1711-7.
1997: Korom S; De Meester I; Stadlbauer T H; Chandraker A; Schaub M; Sayegh M H; Belyaev A; Haemers A; Scharpé S; Kupiec-Weglinski J W
Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.
Transplantation 1997;63(10):1495-500.
1997: Stadlbauer T H; Kupiec-Weglinski J W
Immunobiology of sensitization in transplant recipients.
The American journal of the medical sciences 1997;313(5):268-74.
1997: Onodera K; Lehmann M; Volk H D; Sayegh M H; Kupiec-Weglinski J W
CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
Transplantation proceedings 1997;29(3):1907-8.
1997: Coito A J; Brown L F; Peters J H; Kupiec-Weglinski J W; van de Water L
Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.
The American journal of pathology 1997;150(5):1757-72.
1997: Onodera K; Hancock W W; Graser E; Volk H D; Lehmann M; Chandraker A; Sayegh M H; Kupiec-Weglinski J W
Th2-type cytokines in the "infectious" tolerance pathway.
Transplantation proceedings 1997;29(1-2):1290-1.
1997: Korom S; De Meester I; Onodera K; Stadlbauer T H; Borloo M; Lambeir A M; Kupiec-Weglinski J W
The effects of CD26/DPP IV-targeted therapy on acute allograft rejection.
Transplantation proceedings 1997;29(1-2):1274-5.
1997: Coito A J; Korom S; Van de Water L; Kupiec-Weglinski J W
Distinct fibronectin splicing variants: potential targets for therapeutic immunomodulation in organ allograft recipients.
Transplantation proceedings 1997;29(1-2):1060-1.
1997: Stadlbauer T H; Onodera K; Schaub M; Korom S; Binder J; Sayegh M H; Kupiec-Weglinski J W
Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Transplantation proceedings 1997;29(1-2):1016.
1997: Schmidbauer G; Homeyer A; Bohle R M; Grimm H; Binder J; Kupiec-Weglinski J W
Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
Transplantation proceedings 1997;29(1-2):607-8.
1997: Wasowska B; Hancock W W; Onodera K; Korom S; Stadlbauer T H; Zheng X X; Strom T B; Kupiec-Weglinski J W
Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts.
Transplantation proceedings 1997;29(1-2):333.
1997: Onodera K; Hancock W W; Graser E; Lehmann M; Sayegh M H; Strom T B; Volk H D; Kupiec-Weglinski J W
Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(4):1572-81.
1996: Onodera K; Lehmann M; Akalin E; Volk H D; Sayegh M H; Kupiec-Weglinski J W
Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(5):1944-50.
1996: Binder J; Lehmann M; Graser E; Hancock W W; Watschinger B; Onodera K; Sayegh M H; Volk H D; Kupiec-Weglinski J W
The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Transplantation 1996;61(5):804-11.
1996: Wasowska B; Wieder K J; Hancock W W; Zheng X X; Berse B; Binder J; Strom T B; Kupiec-Weglinski J W
Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(1):395-404.
1996: Kupiec-Weglinski J W
Graft rejection in sensitized recipients.
Annals of transplantation : quarterly of the Polish Transplantation Society 1996;1(1):34-40.
1996: Coito A J; Kupiec-Weglinski J W
Extracellular matrix proteins: bystanders or active participants in the allograft rejection cascade?
Annals of transplantation : quarterly of the Polish Transplantation Society 1996;1(3):14-8.
1995: Binder J; Graser E; Hancock W W; Wasowska B; Sayegh M H; Volk H D; Kupiec-Weglinski J W
Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients.
Transplantation 1995;60(12):1516-24.
1995: Coito A J; Binder J; Brown L F; de Sousa M; Van de Water L; Kupiec-Weglinski J W
Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(6):2949-58.
1995: Coito A J; Binder J; Brown L F; de Sousa M; Van de Water L; Kupiec-Weglinski J W
TNF-alpha upregulates the expression of fibronectin in acutely rejecting rat cardiac allografts.
Transplantation proceedings 1995;27(1):463-5.
1995: Schmidbauer G; Hancock W W; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski J W
Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
Transplantation proceedings 1995;27(1):427-9.
1995: Wasowska B; Wieder K J; Hancock W W; Berse B; Binder J; Strom T B; Kupiec-Weglinski J W
Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Transplantation proceedings 1995;27(1):423-6.
1995: Binder J; Hancock W W; Watschinger B; Wasowska B; Sayegh M H; Kupiec-Weglinski J W
Abrogation of accelerated allograft rejection by intrathymic injection of donor spleen cells is associated with upregulation of donor-reactive IgM, IgG1, and IgG2A, but depression of IgG2B in the circulation and at the graft site.
Transplantation proceedings 1995;27(1):138-41.
1995: Binder J; Hancock W W; Wasowska B; Gallon L; Watschinger B; Sayegh M H; Brock J; Lehmann M; Volk H D; Kupiec-Weglinski J W
Donor-specific transplantation unresponsiveness in sensitized rats following treatment with a nondepleting anti-CD4 MAb is associated with selective intragraft sparing of Th2-like cells.
Transplantation proceedings 1995;27(1):114-6.
1995: Binder J; Hancock W W; Watschinger B; Wasowska B; Sayegh M H; Kupiec-Weglinski J W
The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
Transplantation 1995;59(4):590-7.
1994: Binder J; Mishina E V; Jusko W J; Kupiec-Weglinski J W
Prolongation of cardiac allograft survival in rats by liposome-encapsulated methylprednisolone.
Transplantation 1994;58(5):633-5.
1994: Binder J; Sayegh M H; Watschinger B; Hancock W W; Kupiec-Weglinski J W
Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
Transplantation 1994;58(1):80-6.
1994: Coito A J; De Sousa M; Kupiec-Weglinski J W
The role of cellular and extracellular matrix adhesion proteins in organ transplantation.
Cell adhesion and communication 1994;2(3):249-55.
1994: Schmidbauer G; Hancock W W; Wasowska B; Badger A M; Kupiec-Weglinski J W
Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
Transplantation 1994;57(6):933-41.
1994: Coito A J; Binder J; de Sousa M; Kupiec-Weglinski J W
The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.
Transplantation 1994;57(4):599-605.
1993: Kupiec-Weglinski J W; Wasowska B; Papp I; Schmidbauer G; Sayegh M H; Baldwin W M; Wieder K J; Hancock W W
CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(9):5053-61.
1993: Whitley W D; Hancock W W; Kupiec-Weglinski J W; DeSousa M; Tilney N L
Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats.
Transplantation 1993;56(5):1182-8.
1993: Wieder K J; Hancock W W; Schmidbauer G; Corpier C L; Wieder I; Kobzik L; Strom T B; Kupiec-Weglinski J W
Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(2):1158-66.
1993: Schmidbauer G; Hancock W W; Badger A M; Kupiec-Weglinski J W
Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
Transplantation 1993;55(6):1236-43.
1993: Kupiec-Weglinski J W; Heemann U W; Coito A J; Tullius S G; Tilney N L; de Sousa M
Adhesion molecule interaction with extracellular matrix.
Experimental nephrology 1993;1(2):78-82.
1993: Schmidbauer G; Hancock W W; Wasowska B A; Sablinski T; Kupiec-Weglinski J W
Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
Transplantation proceedings 1993;25(1 Pt 1):712-3.
1993: Sablinski T; Hancock W W; Wasowska B A; Schmidbauer G; Baldwin W M; Kut J P; Milford E L; Kupiec-Weglinski J W
Modulation of acute and hyperacute rejection of xenografts in concordant hamster-to-rat combination.
Transplantation proceedings 1993;25(1 Pt 1):432-4.
1993: Schmidbauer G; Hancock W W; Badger A M; Kupiec-Weglinski J W
SK&F 105685 treatment induces suppressor cell activity and modulates cell adhesion properties in rat recipients of cardiac allografts.
Transplantation proceedings 1993;25(1 Pt 1):758-60.
1992: Tanaka K; Tilney N L; Kupiec-Weglinski J W
Maturing thymocytes in accelerated rejection of cardiac allografts in presensitized rats.
Transplantation 1992;54(3):515-9.
1992: Sablinski T; Sayegh M H; Kut J P; Milford E L; Tilney N L; Kupiec-Weglinski J W
Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.
Transplantation 1992;54(2):292-6.
1992: Hancock W W; Sayegh M H; Sablinski T; Kut J P; Kupiec-Weglinski J W; Milford E L
Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
Transplantation 1992;53(6):1276-80.
1992: Sablinski T; Hancock W W; Schmidbauer G; Milford E L; Kupiec-Weglinski J W
CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
Transplantation proceedings 1992;24(2):528-30.
1992: Papp I; Wieder K J; Sablinski T; O'Connell P J; Milford E L; Strom T B; Kupiec-Weglinski J W
Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(5):1308-14.
1992: Hancock W W; Schmidbauer G; Badger A M; Kupiec-Weglinski J W
SK&F 105685 suppresses allogeneically induced mononuclear and endothelial cell activation and cytokine production and prolongs rat cardiac allograft survival.
Transplantation proceedings 1992;24(1):231-2.
1992: Hancock W W; Whitley D; Kupiec-Weglinski J W; Tilney N L
Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
Transplantation proceedings 1992;24(1):214-5.
1992: Sablinski T; Sayegh M H; Kut J P; Tilney N L; Milford E L; Kupiec-Weglinski J W
The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
Transplantation 1992;53(1):219-21.
1991: Sablinski T; Hancock W W; Tilney N L; Kupiec-Weglinski J W
CD4 monoclonal antibodies in organ transplantation--a review of progress.
Transplantation 1991;52(4):579-89.
1991: Ueda H; Cheung Y C; Masetti P; Diaco M; McCarter M; Kupiec-Weglinski J W; Tilney N L;
Synergy between cyclosporine and anti-IL-2 receptor monoclonal antibodies in rats. Functional studies of heart and kidney allografts.
Transplantation 1991;52(3):437-42.
1991: Tilney N L; Whitley W D; Diamond J R; Kupiec-Weglinski J W; Adams D H
Chronic rejection--an undefined conundrum.
Transplantation 1991;52(3):389-98.
1991: Kupiec-Weglinski J W; De Sousa M
Lymphocyte traffic is modified in vivo by anti-laminin antibody.
Immunology 1991;72(2):312-3.
1991: Kupiec-Weglinski J W; Sablinski T; Hancock W W; Mix C T; Tilney N L
Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
Transplantation proceedings 1991;23(1 Pt 1):285-6.
1991: Tanaka K; Kupiec-Weglinski J W; Hancock W W; Stunkel K; Diamantstein T; Tilney N L
Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Transplantation proceedings 1991;23(1 Pt 1):281-2.
1991: Sablinski T; Sayegh M H; Kut J P; Hancock W W; Milford E L; Tilney N L; Kupiec-Weglinski J W
Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
Transplantation proceedings 1991;23(1 Pt 1):268-9.
1991: Kupiec-Weglinski J W; Sablinski T; Hancock W W; Di Stefano R; Mariani G; Mix C T; Tilney N L
Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
Transplantation 1991;51(2):300-5.
1991: Sayegh M H; Sablinski T; Tanaka K; Kut J P; Kwok C A; Tilney N L; Kupiec-Weglinski J W; Milford E L
Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment.
Transplantation 1991;51(2):296-9.
1991: Sablinski T; Sayegh M H; Hancock W W; Kut J P; Kwok C A; Milford E L; Tilney N L; Kupiec-Weglinski J W
Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection.
Transplantation 1991;51(1):226-31.
1990: Ueda H; Hancock W W; Cheung Y C; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
Transplantation 1990;50(4):545-50.
1990: Tanaka K; Turka L A; Kupiec-Weglinski J W; Milford E L; Ueda H; Diamantstein T; Carpenter C B; Tilney N L
Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
Transplantation 1990;50(1):125-31.
1990: Ueda H; Hancock W W; Cheung Y C; Tanaka K; Kupiec-Weglinski J W; Tilney N L
Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia.
Transplantation 1990;49(6):1124-9.
1989: Tanaka K; Hancock W W; Osawa H; Stunkel K G; Alberghini T V; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(9):2873-9.
1989: Kupiec-Weglinski J W; Mariani G; Tanaka K; Di Stefano R; Stünkel K G; Diamantstein T; Tilney N L
Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
Cellular immunology 1989;123(1):148-57.
1989: Diamantstein T; Kupiec-Weglinski J W; Strom T B; Tilney N L
Current stage of interleukin 2 receptor targeted therapy.
Experimental and clinical endocrinology 1989;93(2-3):114-24.
1989: Kupiec-Weglinski J W; Tilney N L
Lymphocyte migration patterns in organ allograft recipients.
Immunological reviews 1989;108():63-82.
1989: DiStefano R; Uhteg L C; Hancock W W; Araneda D; Kupiec-Weglinski J W; Tilney N L
Host-graft relationship in accelerated rejection of rat cardiac allografts.
Transplantation proceedings 1989;21(1 Pt 1):496-7.
1989: Lord R H; Padberg W M; Hancock W W; Kupiec-Weglinski J W; Tilney N L
Correlation of macrophage and NK cell numbers with "activation markers" in rat cardiac allografts.
Transplantation proceedings 1989;21(1 Pt 1):449-50.
1989: Tanaka K; Turka L A; Ueda H; Diamantstein T; Milford E L; Carpenter C B; Tilney N L; Kupiec-Weglinski J W
Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
Transplantation proceedings 1989;21(1 Pt 1):475-6.
1989: Tilney N L; Kupiec-Weglinski J W
Advances in the understanding of rejection mechanisms.
Transplantation proceedings 1989;21(1 Pt 1):10-3.
1989: Turka L A; Tanaka K; Kupiec-Weglinski J W; Milford E L; Tilney N L; Carpenter C B
In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats.
Transplantation 1989;47(2):388-90.
1989: Kupiec-Weglinski J W; van der Meide P; Stunkel K G; Tanaka K; Diamantstein T; Tilney N L
Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
Transplantation proceedings 1989;21(1 Pt 1):992-3.
1989: Kupiec-Weglinski J W; Tilney N L; Stunkel K G; Grutzmann R; van der Meide P H; Di Stefano R; Diamantstein T
Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
Transplantation 1989;47(1):11-6.
1988: Kupiec-Weglinski J W; Diamantstein T; Tilney N L
Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation.
Transplantation 1988;46(6):785-92.
1988: Tilney N L; Padberg W M; Lord R H; Araneda D; Strom T B; Kupiec-Weglinski J W
Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipients.
Transplantation 1988;46(2 Suppl):122S-128S.
1988: Tilney N L; Strom T B; Kupiec-Weglinski J W
Pharmacologic and immunologic agonists and antagonists of cyclosporine.
Transplantation proceedings 1988;20(3 Suppl 3):13-22.
1988: Padberg W M; Lord R H; Araneda D; Tilney N L; Kupiec-Weglinski J W
Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts.
Transplantation proceedings 1988;20(3 Suppl 3):1053-6.
1988: Di Stefano R; Mouzaki A; Araneda D; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.
The Journal of experimental medicine 1988;167(6):1981-6.
1988: Lord R H; Padberg W M; Di Stefano R; Hancock W W; Araneda D; Rickles F R; Tilney N L; Kupiec-Weglinski J W
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allografts.
Transplantation proceedings 1988;20(2):229-30.
1988: DiStefano R; Kupiec-Weglinski J W; Uhteg L C; Puskas J; Araneda D; Diamantstein T; Tilney N L
Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18.
Transplantation proceedings 1988;20(2 Suppl 2):217-22.
1988: Kupiec-Weglinski J W; Hahn H J; Kirkman R L; Volk H D; Mouzaki A; DiStefano R; Tellides G; Dallman M; Morris P J; Strom T B
Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
Transplantation proceedings 1988;20(2 Suppl 2):207-16.
1988: Kupiec-Weglinski J W; Di Stefano R; Stunkel K G; Grutzmann R; Theisen P; Araneda D; Tilney N L; Diamantstein T
Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
Transplantation proceedings 1988;20(1 Suppl 1):272-5.
1988: Padberg W M; Lord R H; Di Stefano R; Araneda D; Tilney N L; Kupiec-Weglinski J W
Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allografts.
Transplantation 1988;45(1):162-8.
1988: Diamantstein T; Mouzaki A; Osawa H; Volk H D; Hahn H J; Kirkman R L; Strom T B; Tilney N L; Kupiec-Weglinski J W
Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.
Developments in biological standardization 1988;69():177-84.
1987: Tilney N L; Strom T B; Kupiec-Weglinski J W
Humoral and cellular mechanisms in acute allograft injury.
The Journal of pediatrics 1987;111(6 Pt 2):1000-3.
1987: Padberg W; Schwemmle K; Dobroschke J; Kupiec-Weglinski J W; Tilney N L
[Immunosuppressive therapy in transplantation surgery]
Deutsche medizinische Wochenschrift (1946) 1987;112(43):1670-4.
1987: Padberg W M; Di Stefano R; Lord R H; Araneda D; Strom T B; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation.
Transplantation proceedings 1987;19(5):4234-5.
1987: Padberg W M; Lord R H; Kupiec-Weglinski J W; Williams J M; Di Stefano R; Thornburg L E; Araneda D; Strom T B; Tilney N L
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(6):1751-7.
1987: Padberg W M; Kupiec-Weglinski J W; Lord R H; Araneda D H; Tilney N L
W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(11):3669-74.
1987: Kupiec-Weglinski J W; Padberg W; Uhteg L C; Ma L; Lord R H; Araneda D; Strom T B; Diamantstein T; Tilney N L
Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
European journal of immunology 1987;17(3):313-9.
1987: Padberg W M; Kupiec-Weglinski J W; Lord R H; Towpik E; Tilney N L
W3/25+ T cells mediate specific unresponsiveness in enhanced allograft recipients.
Transplantation proceedings 1987;19(1 Pt 1):493-4.
1987: Lord R H; Hancock W W; Colby A J; Padberg W; Diamantstein T; Kupiec-Weglinski J W; Tilney N L
Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
Transplantation proceedings 1987;19(1 Pt 1):354-5.
1987: Kupiec-Weglinski J W; Padberg W; Uhteg L C; Towpik E; Lord R H; Ma L; Diamantstein T; Strom T B; Tilney N L
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
Transplantation proceedings 1987;19(1 Pt 1):591-3.
1987: Towpik E; Kupiec-Weglinski J W; Uhteg L C; Padberg W; Tilney N L
Immune responsiveness following skin grafting in cyclosporine-treated rats.
Transplantation proceedings 1987;19(1 Pt 1):497-8.
1986: Schneider T M; Kupiec-Weglinski J W; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom T B; Tilney N L
Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
Transplantation 1986;42(2):191-6.
1986: Schneider T M; Kupiec-Weglinski J W; Towpik E; Strom T B; Tilney N L
Studies on mechanisms of acute rejection of vascularized organ allografts.
Human immunology 1986;15(3):320-9.
1985: Towpik E; Kupiec-Weglinski J W; Schneider T M; Tyler D; Padberg W; Araneda D; Tilney N L
Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
Transplantation 1985;40(6):714-8.
1985: Kupiec-Weglinski J W; Towpik E; Schneider T M; Araneda D; Ma L; Tilney N L
T suppressor lymphocytes reverse ongoing acute allograft rejection.
Human immunology 1985;14(3):270-8.
1985: Heidecke C D; Araujo J L; Kupiec-Weglinski J W; Abbud-Filho M; Araneda D; Stadler J; Siewert J; Strom T B; Tilney N L
Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts.
Transplantation 1985;40(4):441-4.
1985: Araujo J L; Kupiec-Weglinski J W; Araneda D; Towpik E; Heidecke C D; Williams J M; Tilney N L
Phenotype, activation status, and suppressor activity of host lymphocytes during acute rejection and after cyclosporine-induced unresponsiveness of rat cardiac allografts.
Transplantation 1985;40(3):278-84.
1985: Kupiec-Weglinski J W; Heidecke C D; Araujo J L; Abbud-Filho M; Towpik E; Araneda D; Strom T B; Tilney N L
Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
Cellular immunology 1985;93(1):168-77.
1984: Abbud-Filho M; Kupiec-Weglinski J W; Araujo J L; Heidecke C D; Tilney N L; Strom T B
Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
Journal of immunology (Baltimore, Md. : 1950) 1984;133(5):2582-6.
1984: Heidecke C D; Kupiec-Weglinski J W; Lear P A; Abbud-Filho M; Araujo J L; Araneda D; Strom T B; Tilney N L
Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(2):582-8.
1984: Kupiec-Weglinski J W; Lear P A; Heidecke C D; Tilney N L
Modification of function and migration patterns of thymocyte populations by cyclosporine after organ transplantation in rats.
Transplantation 1984;37(6):631-3.
1984: Kupiec-Weglinski J W; Lear P A; Heidecke C D; Araneda D; Tilney N L
Restoration of allograft responsiveness in B rats. IV. The divergent migratory behavior of lymphocyte populations mediating cardiac allograft rejection.
Cellular immunology 1984;85(2):459-76.
1984: Tilney N L; Kupiec-Weglinski J W; Heidecke C D; Lear P A; Strom T B
Mechanisms of rejection and prolongation of vascularized organ allografts.
Immunological reviews 1984;77():185-216.
1983: Lear P A; Heidecke C D; Kupiec-Weglinski J W; Araneda D; Strom T B; Tilney N L
Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine.
Transplantation 1983;36(4):412-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

JW Kupiec-Weglinski

Research Profile (preview)

Procedures

Living Beings

Physiology

Chemicals & Drugs

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of JW Kupiec-Weglinski (preview)

All Publications